RCM News and Press, R1 RCM Inc. From 08/31/22

MURRAY, Utah, Aug. 31, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announced an agreement to be the exclusive provider of r...

MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with St. Clair Health to serve as its primary provider of end-to-end revenue cycle management (RCM) services.  St. Clair Health is a nationally rec...

R1 RCM Inc. (RCM) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Joseph Flanagan - President & Chief Executive Officer Lee Rivas - President Rachel Wilson - Executive Vice President, C...

R1 RCM press release ( NASDAQ: RCM ): Q2 GAAP EPS of -$0.07 misses by $0.11 . Revenue of $391.9M (+10.9% Y/Y) in-line. 2022 Outlook For 2022, R1 expects to generate: Revenue of between $1,850 million and $1,870 million GAAP operating income of $...

MURRAY, Utah, Aug. 03, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2022. ...

R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is $0.08 (+103.7% Y/Y) and the consensus Revenue Estimate is $391.58M (+10.8% Y/Y). Over the last 1 year, RCM has beaten EPS e...

ABC , ALE , OTCPK:AMKBY , AMRN , AROC , ATHM , AVA , AY , BCO , BDC , BERY , BFLY , BGCP , BIP , OTCPK:BMWYY , BRSP , BRY , BWA , CARS , CCRD , CDW , CLDT , CLH , CRL , CRTO , CSTE , ...

MURRAY, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ...

R1 RCM’s intra-quarter guidance update was net positive, with a downward revision for Q2 2022 offset by a stronger 2022/2023 outlook. Cloudmed equips RCM with a complete one-stop offering, further accelerating its growth outlook over the long run. With RCM well on its way t...

Gainers: NexImmune ( NEXI ) +34% . Allogene Therapeutics ALLO +12% . SOPHiA GENETICS ( SOPH ) +12% . Verona Pharma ( VRNA ) +8% . R1 RCM ( RCM ) +7% . Losers: Codexis ( CDXS ) -43% . 10x Genomics ( TXG ...